Bank of Montreal
PTX

Bank of Montreal’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bank of Montreal’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-27,100
Closed -$11K – 5100
2018
Q4 		$11K Sell
27,100
-38,000
-58% -$23.6K ﹤0.01% 3872
2018
Q3 		$63K Buy
65,100
+2,100
+3% +$3.51K ﹤0.01% 3293
2018
Q2 		$153K Buy
63,000
+60,000
+2,000% +$147K ﹤0.01% 2901
2018
Q1 		$7K Buy
+3,000
New +$7.57K ﹤0.01% 3874

Bank of Montreal's PTX Position: Q1 2019 in Review

Bank of Montreal sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 27,100 shares — an estimated $11K sold.

Bank of Montreal first reported a position in PTX in Q2 2014 and held it in 13 quarters. The position peaked at $11.5M in Q2 2014. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • Bank of Montreal reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • Bank of Montreal sold 27,100 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $11K.
  • Bank of Montreal first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 13 quarters.
  • Bank of Montreal's Pernix Therapeutics Holdings, Inc. position peaked at $11.5M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.